Search Results - Moiseyenko, V

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

    Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines by Talbot, D C, Moiseyenko, V, Van Belle, S, O'Reilly, S M, Alba Conejo, E, Ackland, S, Eisenberg, P, Melnychuk, D, Pienkowski, T, Burger, H-U, Laws, S, Osterwalder, B

    Published 2002
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

    Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma by Plummer, R, Lorigan, P, Brown, E, Zaucha, R, Moiseyenko, V, Demidov, L, Soriano, V, Chmielowska, E, Andrés, R, Kudryavtseva, G, Kahatt, C, Szyldergemajn, S, Extremera, S, de Miguel, B, Cullell-Young, M, Calvert, H

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial

    Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial by Esteva, F. J., Baranau, Y. V., Baryash, V., Manikhas, A., Moiseyenko, V., Dzagnidze, G., Zhavrid, E., Boliukh, D., Stroyakovskiy, D., Pikiel, J., Eniu, A. E., Li, R. K., Rusyn, A. V., Tiangco, B., Lee, S. J., Lee, S. Young, Yu, S. Y., Stebbing, J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

    First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study by Van Cutsem, E., Danielewicz, I., Saunders, M. P., Pfeiffer, P., Argilés, G., Borg, C., Glynne-Jones, R., Punt, C. J. A., Van de Wouw, A. J., Fedyanin, M., Stroyakovskiy, D., Kroening, H., Garcia-Alfonso, P., Wasan, H., Falcone, A., Fougeray, R., Egorov, A., Amellal, N., Moiseyenko, V.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

    A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer by Schoemaker, N E, Kuppens, I E L M, Moiseyenko, V, Glimelius, B, Kjaer, M, Starkhammer, H, Richel, D J, Smaaland, R, Bertelsen, K, Poulsen, J P, Voznyi, E, Norum, J, Fennelly, D, Tveit, K M, Garin, A, Gruia, G, Mourier, A, Sibaud, D, Lefebvre, P, Beijnen, J H, Schellens, J H M, ten Bokkel Huinink, W W

    Published 2004
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Hereditary Breast-Ovarian Cancer Syndrome in Russia

    Hereditary Breast-Ovarian Cancer Syndrome in Russia by Sokolenko, A.P., Iyevleva, A.G., Mitiushkina, N.V., Suspitsin, E.N., Preobrazhenskaya, E.`V., Kuligina, E.Sh., Voskresenskiy, D.A., Lobeiko, O.S., Krylova, N.Yu., Gorodnova, T.V., Buslov, K.G., Bit-Sava, E.M., Dolmatov, G.D., Porhanova, N.V., Polyakov, I.S., Abysheva, S.N., Katanugina, A.S., Baholdin, D.V., Yanus, G.A., Togo, A.V., Moiseyenko, V.M., Maximov, S.Ya., Semiglazov, V.F., Imyanitov, E.N.

    Published 2010
    Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: